Drug Trial Radar · NCT06651112
The ATP Project (Antipsychotic-TEP-Psychosis)
Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
18
Planned (sponsor's estimate)
Start
Nov 1, 2024
Primary completion
Dec 1, 2027
Study completion Jun 1, 2028
Sponsor
- Lead sponsor
- Université de SherbrookeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Baszucki Brain Research Fund
- First posted
- Oct 21, 2024
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational study is to the early impacts of psychosis and antipsychotic medications on brain metabolism in young adults recently diagnosed with a first episode of psychosis. The main question aims to evaluate the effect of 4 to 6 weeks of antipsychotic medication on brain metabolism measured by PET scan (cerebral uptake of 11C-Acetoacetate + 18 Fluorodeoxyglucose). Participants will undergo a multimodal imaging protocol with other measures of psychopathology (e.g., cognition, depressive symptoms, etc.) and (metabolic marker, inflammation, etc).
Conditions
- First Episose Psychosis
- Metabolic Disease
- Psychosis; Episode
Interventions
Antipsychotic drugsDrug
Any Antipsychotic drugs prescripbe as standrd of care for this specific populaton
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cerebral metabolic rate of glucose and acetotacetateTime frame: BEFORE introduction of antipsychotic medicationand AFTER 4 to 6 weeks
- Net inflow of glucose and acetoacetateTime frame: BEFORE introduction of antipsychotic medicationand AFTER 4 to 6 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hotel-Dieu CIUSSS de l'Estrie-CHUS
Sherbrooke, Quebec, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.